Remdesivir

The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients in a federally funded study. But there's not enough of the medicine to go around. Ulrich Perrey/Pool/AFP via Getty Images hide caption toggle caption Ulrich Perrey/Pool/AFP via Getty Images The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients…

July 5, 2020 | 4:29pm Enlarge Image Commissioner of the US Food and Drug Administration Stephen Hahn AP The US government is sending a “surge” supply of coronavirus drug remdesivir to areas that need it most, the FDA commissioner said Sunday. Dr. Stephen Hahn told CNN’s “State of the Union” that the Department of Health…

14 ReferencesRelated ArticlesAbstract BackgroundAlthough several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), none have yet been shown to be efficacious. MethodsWe conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement. Patients were randomly assigned to receive either…

Last week saw three studies with seemingly contradictory results about the antiviral drug remdesivir, culminating in the Food and Drug Administration (FDA) granting Emergency Use Authorization (EUA). What happened, exactly?Share on PinterestDoctors in the United States can now use the antiviral drug remdesivir to treat severe COVID-19.Until last weekend, treatment for COVID-19 was primarily experimental.…

Published on Apr 29, 2020The antiviral medication proved effective in clinical trials and has a “clear-cut significant positive effect” in cutting down on recovery time, Dr. Anthony Fauci said today. The drug is administered in IV form to the sickest COVID-19 patients and is expected to get emergency FDA approval.» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC»…